02-BRE-38AV: A Phase III Randomized Study of Three Different Doses of Weekly Docetaxel as First Line Treatment of Metastatic Breast Cancer

  • Romond, Edward (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date6/3/0310/31/05